Bulgaria: $10 million have been invested in a program of clinical reserches on biotech drugs
More than $10 million have been invested in a program of clinical reserches on biotech drugs for the last five years in Bulgaria. That was pointed out by Dr. Krasimira Chemishanska, CEO “Amgen Bulgaria” at the science conference “ Innovations in the biotechs – the future medicine” held in Sofia on 31th October. Dr. Chemishanska explained that the development of a single drug is a huge investment of time and financial resources as well as is associated with a significant risk for manufacturer. Between 10 to 15 years takes the development process and the investment could exceed 1 billion dollars.
Pin It
